메뉴 건너뛰기




Volumn 31, Issue 7, 2016, Pages 1114-1121

Systemic complement activation and complement gene analysis in enterohaemorrhagic Escherichia coli-associated paediatric haemolytic uraemic syndrome

Author keywords

Complement; Complement inhibition; Haemolytic uraemic syndrome; Mutations

Indexed keywords

COMPLEMENT COMPONENT C3D; ECULIZUMAB; BIOLOGICAL MARKER; COMPLEMENT; COMPLEMENT INHIBITOR; MONOCLONAL ANTIBODY; TRANSCRIPTOME;

EID: 85007367202     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw078     Document Type: Article
Times cited : (21)

References (33)
  • 1
    • 15244348050 scopus 로고    scopus 로고
    • Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
    • Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073–1086
    • (2005) Lancet , vol.365 , pp. 1073-1086
    • Tarr, P.I.1    Gordon, C.A.2    Chandler, W.L.3
  • 2
    • 33645557561 scopus 로고    scopus 로고
    • Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome
    • Zimmerhackl LB, Besbas N, Jungraithmayr T et al. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost 2006; 32: 113–120
    • (2006) Semin Thromb Hemost , vol.32 , pp. 113-120
    • Zimmerhackl, L.B.1    Besbas, N.2    Jungraithmayr, T.3
  • 3
    • 84947260202 scopus 로고    scopus 로고
    • An international consensus approach to the management of atypical hemolytic uremic syndrome in children
    • Loirat C, Fakhouri F, Ariceta G et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pe-diatr Nephrol 2016; 31: 15–39
    • (2016) Pe-Diatr Nephrol , vol.31 , pp. 15-39
    • Loirat, C.1    Fakhouri, F.2    Ariceta, G.3
  • 4
    • 0017595341 scopus 로고
    • Breakdown products of C3 and factor B in hemolytic-uremic syndrome
    • Kim Y, Miller K, Michael AF. Breakdown products of C3 and factor B in hemolytic-uremic syndrome. J Lab Clin Med 1977; 89: 845–850
    • (1977) J Lab Clin Med , vol.89 , pp. 845-850
    • Kim, Y.1    Miller, K.2    Michael, A.F.3
  • 5
    • 0018851755 scopus 로고
    • The complement system in hemolytic-uremic syndrome in childhood
    • Monnens L, Molenaar J, Lambert PH et al. The complement system in hemolytic-uremic syndrome in childhood. Clin Nephrol 1980; 13: 168–171
    • (1980) Clin Nephrol , vol.13 , pp. 168-171
    • Monnens, L.1    Molenaar, J.2    Lambert, P.H.3
  • 6
    • 73649122762 scopus 로고    scopus 로고
    • Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome
    • Thurman JM, Marians R, Emlen W et al. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009; 4: 1920–1924
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 1920-1924
    • Thurman, J.M.1    Marians, R.2    Emlen, W.3
  • 7
    • 84924358744 scopus 로고    scopus 로고
    • Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome
    • Arvidsson I, Stahl AL, Hedstrom MM et al. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome. J Immunol 2015; 194: 2309–2318
    • (2015) J Immunol , vol.194 , pp. 2309-2318
    • Arvidsson, I.1    Stahl, A.L.2    Hedstrom, M.M.3
  • 8
    • 84930415185 scopus 로고    scopus 로고
    • Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome
    • Ferraris JR, Ferraris V, Acquier AB et al. Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome. Clin Exp Immunol 2015; 181: 118–125
    • (2015) Clin Exp Immunol , vol.181 , pp. 118-125
    • Ferraris, J.R.1    Ferraris, V.2    Acquier, A.B.3
  • 9
    • 80155167232 scopus 로고    scopus 로고
    • Inhibition of terminal complement activation in severe Shiga toxin-associated HUS - Perfect example for a fast track from bench to bedside
    • Orth-Holler D, Riedl M, Wurzner R. Inhibition of terminal complement activation in severe Shiga toxin-associated HUS - perfect example for a fast track from bench to bedside. EMBO Mol Med 2011; 3: 617–619
    • (2011) EMBO Mol Med , vol.3 , pp. 617-619
    • Orth-Holler, D.1    Riedl, M.2    Wurzner, R.3
  • 10
    • 84902294881 scopus 로고    scopus 로고
    • Role of complement in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome
    • Orth-Holler D, Wurzner R. Role of complement in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Semin Thromb Hemost 2014; 40: 503–507
    • (2014) Semin Thromb Hemost , vol.40 , pp. 503-507
    • Orth-Holler, D.1    Wurzner, R.2
  • 11
    • 79959776422 scopus 로고    scopus 로고
    • Eculizumab in severe Shiga-toxin-associated HUS
    • Lapeyraque A, Malina M, Fremeaux-Bacchi V et al. Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 2011; 364: 2561–2563
    • (2011) N Engl J Med , vol.364 , pp. 2561-2563
    • Lapeyraque, A.1    Malina, M.2    Fremeaux-Bacchi, V.3
  • 12
    • 84941369290 scopus 로고    scopus 로고
    • Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement
    • Pape L, Hartmann H, Bange FC et al. Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement. Medicine (Baltimore) 2015; 94: e1000
    • (2015) Medicine (Baltimore) , vol.94
    • Pape, L.1    Hartmann, H.2    Bange, F.C.3
  • 13
    • 84868562798 scopus 로고    scopus 로고
    • Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. Coli O104:H4 induced haemolytic-uraemic syndrome: An analysis of the German STEC-HUS registry
    • Kielstein JT, Beutel G, Fleig S et al. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 2012; 27: 3807–3815
    • (2012) Nephrol Dial Transplant , vol.27 , pp. 3807-3815
    • Kielstein, J.T.1    Beutel, G.2    Fleig, S.3
  • 14
    • 84865491675 scopus 로고    scopus 로고
    • An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: Presentation and short-term outcome in children
    • Loos S, Ahlenstiel T, Kranz B et al. An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 2012; 55: 753–759
    • (2012) Clin Infect Dis , vol.55 , pp. 753-759
    • Loos, S.1    Ahlenstiel, T.2    Kranz, B.3
  • 15
    • 0002630748 scopus 로고
    • Complement and complement fixation
    • Kabat E, Mayer MM (eds.) Springfield, IL: CC Thomas
    • Mayer MM. Complement and complement fixation. In: Kabat E, Mayer MM (eds). Experimental Immunochemistry. Springfield, IL: CC Thomas, 1961, 133–240
    • (1961) Experimental Immunochemistry , pp. 133-240
    • Mayer, M.M.1
  • 16
    • 0020682488 scopus 로고
    • A study of optimal reaction conditions for an assay of the human alternative complement pathway
    • Joiner KA, Hawiger A, Gelfand JA. A study of optimal reaction conditions for an assay of the human alternative complement pathway. Am J Clin Pathol 1983; 79: 65–72
    • (1983) Am J Clin Pathol , vol.79 , pp. 65-72
    • Joiner, K.A.1    Hawiger, A.2    Gelfand, J.A.3
  • 17
    • 0021197082 scopus 로고
    • Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d
    • Brandslund I, Teisner B, Hyltoft Petersen P et al. Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d. Scand J Clin Lab Invest Suppl 1984; 168: 57–73
    • (1984) Scand J Clin Lab Invest Suppl , vol.168 , pp. 57-73
    • Brandslund, I.1    Teisner, B.2    Hyltoft Petersen, P.3
  • 18
    • 0031458902 scopus 로고    scopus 로고
    • Molecular, genetic, and functional analysis of homozygous C8 beta-chain deficiency in two siblings
    • Kotnik V, Luznik-Bufon T, Schneider PM et al. Molecular, genetic, and functional analysis of homozygous C8 beta-chain deficiency in two siblings. Immunopharmacology 1997; 38: 215–221
    • (1997) Immunopharmacology , vol.38 , pp. 215-221
    • Kotnik, V.1    Luznik-Bufon, T.2    Schneider, P.M.3
  • 19
    • 0031445962 scopus 로고    scopus 로고
    • Complement factor I deficiency in a family with recurrent infections
    • Leitao MF, Vilela MM, Rutz R et al. Complement factor I deficiency in a family with recurrent infections. Immunopharmacology 1997; 38: 207–213
    • (1997) Immunopharmacology , vol.38 , pp. 207-213
    • Leitao, M.F.1    Vilela, M.M.2    Rutz, R.3
  • 20
    • 84893164403 scopus 로고    scopus 로고
    • Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: The example of retinal dystrophies
    • Eisenberger T, Neuhaus C, Khan AO et al. Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One 2013; 8: e78496
    • (2013) PLoS One , vol.8
    • Eisenberger, T.1    Neuhaus, C.2    Khan, A.O.3
  • 21
    • 84922353943 scopus 로고    scopus 로고
    • An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease
    • Eisenberger T, Decker C, Hiersche M et al. An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease. PLoS One 2015; 10: e0116680
    • (2015) PLoS One , vol.10
    • Eisenberger, T.1    Decker, C.2    Hiersche, M.3
  • 22
    • 84881028445 scopus 로고    scopus 로고
    • ANKS6 is a central component of a ne-phronophthisis module linking NEK8 to INVS and NPHP3
    • Hoff S, Halbritter J, Epting D et al. ANKS6 is a central component of a ne-phronophthisis module linking NEK8 to INVS and NPHP3. Nat Genet 2013; 45: 951–956
    • (2013) Nat Genet , vol.45 , pp. 951-956
    • Hoff, S.1    Halbritter, J.2    Epting, D.3
  • 23
    • 84876338226 scopus 로고    scopus 로고
    • Combined NGS approaches identify mutations in the intraflagellar transport gene IFT140 in skeletal ciliopathies with early progressive kidney Disease
    • Schmidts M, Frank V, Eisenberger T et al. Combined NGS approaches identify mutations in the intraflagellar transport gene IFT140 in skeletal ciliopathies with early progressive kidney Disease. Hum Mutat 2013; 34: 714–724
    • (2013) Hum Mutat , vol.34 , pp. 714-724
    • Schmidts, M.1    Frank, V.2    Eisenberger, T.3
  • 24
    • 38349172121 scopus 로고    scopus 로고
    • Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome
    • Fang CJ, Fremeaux-Bacchi V, Liszewski MK et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 2008; 111: 624–632
    • (2008) Blood , vol.111 , pp. 624-632
    • Fang, C.J.1    Fremeaux-Bacchi, V.2    Liszewski, M.K.3
  • 25
    • 78449293078 scopus 로고    scopus 로고
    • Genetics and complement in atypical HUS
    • Kavanagh D, Goodship T. Genetics and complement in atypical HUS. Pe-diatr Nephrol 2010; 25: 2431–2442
    • (2010) Pe-Diatr Nephrol , vol.25 , pp. 2431-2442
    • Kavanagh, D.1    Goodship, T.2
  • 26
    • 84874610717 scopus 로고    scopus 로고
    • Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype
    • Bresin E, Rurali E, Caprioli J et al. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol 2013; 24: 475–486
    • (2013) J Am Soc Nephrol , vol.24 , pp. 475-486
    • Bresin, E.1    Rurali, E.2    Caprioli, J.3
  • 27
    • 84936802263 scopus 로고    scopus 로고
    • Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels
    • Kavanagh D, Yu Y, Schramm EC et al. Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels. Hum Mol Genet 2015; 24: 3861–3870
    • (2015) Hum Mol Genet , vol.24 , pp. 3861-3870
    • Kavanagh, D.1    Yu, Y.2    Schramm, E.C.3
  • 28
    • 84891753035 scopus 로고    scopus 로고
    • Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome
    • Bu F, Maga T, Meyer NC et al. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2014; 25: 55–64
    • (2014) J Am Soc Nephrol , vol.25 , pp. 55-64
    • Bu, F.1    Maga, T.2    Meyer, N.C.3
  • 29
    • 0026666338 scopus 로고
    • Hypocomplementemia and leuko-cytosis in diarrhea-associated hemolytic uremic syndrome
    • Robson WL, Leung AK, Fick GH et al. Hypocomplementemia and leuko-cytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 1992; 62: 296–299
    • (1992) Nephron , vol.62 , pp. 296-299
    • Robson, W.L.1    Leung, A.K.2    Fick, G.H.3
  • 30
    • 70350693665 scopus 로고    scopus 로고
    • Shiga toxin activates complement and binds factor H: Evidence for an active role of complement in hemolytic uremic syndrome
    • Orth D, Khan AB, Naim A et al. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 2009; 182: 6394–6400
    • (2009) J Immunol , vol.182 , pp. 6394-6400
    • Orth, D.1    Khan, A.B.2    Naim, A.3
  • 31
    • 84880082112 scopus 로고    scopus 로고
    • Shiga toxin-producing Escherichia coli: Factors involved in virulence and cattle colonization
    • Etcheverría AI, Padola NL. Shiga toxin-producing Escherichia coli: factors involved in virulence and cattle colonization. Virulence 2013; 4: 366–372
    • (2013) Virulence , vol.4 , pp. 366-372
    • Etcheverría, A.I.1    Padola, N.L.2
  • 32
    • 0035067379 scopus 로고    scopus 로고
    • Intrarenal synthesis of complement
    • Zhou W, Marsh JE, Sacks SH. Intrarenal synthesis of complement. Kidney Int 2001; 59: 1227–1235
    • (2001) Kidney Int , vol.59 , pp. 1227-1235
    • Zhou, W.1    Marsh, J.E.2    Sacks, S.H.3
  • 33
    • 84902134692 scopus 로고    scopus 로고
    • Spectrum of complement-mediated thrombotic microangiopathies: Pathogenetic insights identifying novel treatment approaches
    • Riedl M, Fakhouri F, Le Quintrec M et al. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost 2014; 40: 444–464
    • (2014) Semin Thromb Hemost , vol.40 , pp. 444-464
    • Riedl, M.1    Fakhouri, F.2    Le Quintrec, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.